The FDA has given its nod to Bydureon, making it the first weekly treatment for type 2 diabetes, according to drug’s manufacturer.
from: http://diabetes.webmd.com/news/20120127/weekly-shot-gets-fda-nod-type-2-diabates?src=RSS_PUBLIC
Related posts:
- FDA Panel Opposes New Type of Diabetes Drug
In a 9-6 vote, an advisory panel said the FDA should not yet approve... - FDA OKs Flu Shot With Smaller Needle
The FDA has approved the first flu shot to be injected with a tiny... - FDA OKs Pill for Diabetes and High Cholesterol
The FDA has approved the first combination pill for treating both type 2 diabetes... - Robot Hair-Transplant Device Gets FDA Nod
The FDA has cleared Restoration Robotics’ Artas System for removing hair follicles from the... - Why Some May Avoid Type 1 Diabetes Complications
Researchers say some type 1 diabetes patients are able to avoid complications from diabetes,...